Decreased lipoprotein lipase activity and increased postprandial concentrations of triglyceride-rich lipoproteins in offspring of elderly survivors of myocardial infarction

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 18, Issue 10, 2008, Pages 700-706

  Lekhal, Samira ^a   Børvik, Trond ^a   Nordøy, Arne ^a   Hansen, John Bjarne ^a  

^a Institute of Clinical Medicine   (Norway)

Author keywords

Lipoprotein lipase activity; Myocardial infarction; Offspring; Postprandial hypertriglyceridemia; Triglyceride rich lipoproteins

Indexed keywords

LIPOPROTEIN; LIPOPROTEIN LIPASE; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD; CASE CONTROL STUDY; FEMALE; GENETICS; HEART INFARCTION; HUMAN; MALE; POSTPRANDIAL STATE; SURVIVOR;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; HUMANS; LIPOPROTEIN LIPASE; LIPOPROTEINS; MALE; MYOCARDIAL INFARCTION; POSTPRANDIAL PERIOD; SURVIVORS; TRIGLYCERIDES;

EID: 55949103580     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2007.10.001     Document Type: Article

References (38)

1. Myers R.H., Kiely D.K., Cupples L.A., and Kannel W.B. Parental history is an independent risk factor for coronary artery disease: the Framingham Study. Am Heart J 120 (1990) 963-969
2. Leander K., Hallqvist J., Reuterwall C., Ahlbom A., and de Faire U. Family history of coronary heart disease, a strong risk factor for myocardial infarction interacting with other cardiovascular risk factors: results from the Stockholm Heart Epidemiology Program (SHEEP). Epidemiology 12 (2001) 215-221
3. Pankow J.S., Folsom A.R., Province M.A., Rao D.C., Eckfeldt J., Heiss G., et al. Family history of coronary heart disease and hemostatic variables in middle-aged adults. Atherosclerosis Risk in Communities Investigators and Family Heart Study Research Group. Thromb Haemost 77 (1997) 87-93
4. Miller N.E., Thelle D.S., Forde O.H., and Mjos O.D. The Tromso heart-study. High-density lipoprotein and coronary heart-disease: a prospective case-control study. Lancet 1 (1977) 965-968
5. Gordon T., Castelli W.P., Hjortland M.C., Kannel W.B., and Dawber T.R. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med 62 (1977) 707-714
6. Uiterwaal C.S., Witteman J.C., van Stiphout W.A., Krauss X.H., de Bruijn A.M., Hofman A., et al. Lipoproteins and apolipoproteins in the young and familial risk of coronary atherosclerosis. Atherosclerosis 122 (1996) 235-244
7. Zilversmit D.B. Atherogenesis: a postprandial phenomenon. Circulation 60 (1979) 473-485
8. Proctor S.D., and Mamo J.C. Arterial fatty lesions have increased uptake of chylomicron remnants but not low-density lipoproteins. Coron Artery Dis 7 (1996) 239-245
9. Proctor S.D., Vine D.F., and Mamo J.C. Arterial permeability and efflux of apolipoprotein B-containing lipoproteins assessed by in situ perfusion and three-dimensional quantitative confocal microscopy. Arterioscler Thromb Vasc Biol 24 (2004) 2162-2167
10. Patsch J.R., Miesenbock G., Hopferwieser T., Muhlberger V., Knapp E., Dunn J.K., et al. Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arterioscler Thromb 12 (1992) 1336-1345
11. Groot P.H., van Stiphout W.A., Krauss X.H., Jansen H., van Tol A., van Ramshorst E., et al. Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease. Arterioscler Thromb 11 (1991) 653-662
12. Karpe F., Steiner G., Uffelman K., Olivecrona T., and Hamsten A. Postprandial lipoproteins and progression of coronary atherosclerosis. Atherosclerosis 106 (1994) 83-97
13. Otarod J.K., and Goldberg I.J. Lipoprotein lipase and its role in regulation of plasma lipoproteins and cardiac risk. Curr Atheroscler Rep 6 (2004) 335-342
14. Olivecrona T. Lipoprotein and hepatic lipases in lipoprotein metabolism. In: Betterbridge D.J., Illingworth D.R., and Shepard J. (Eds). Lipoproteins in health and disease (1999), Arnold, London 223-246
15. Brunzell J.D., Miller N.E., Alaupovic P., St Hilaire R.J., Wang C.S., Sarson D.L., et al. Familial chylomicronemia due to a circulating inhibitor of lipoprotein lipase activity. J Lipid Res 24 (1983) 12-19
16. Jukema J.W., van Boven A.J., Groenemeijer B., Zwinderman A.H., Reiber J.H., Bruschke A.V., et al. The Asp9 Asn mutation in the lipoprotein lipase gene is associated with increased progression of coronary atherosclerosis. REGRESS Study Group, Interuniversity Cardiology Institute, Utrecht, The Netherlands. Regression Growth Evaluation Statin Study. Circulation 94 (1996) 1913-1918
17. Tornvall P., Olivecrona G., Karpe F., Hamsten A., and Olivecrona T. Lipoprotein lipase mass and activity in plasma and their increase after heparin are separate parameters with different relations to plasma lipoproteins. Arterioscler Thromb Vasc Biol 15 (1995) 1086-1093
18. Jackson R.L., Yates M.T., McNerney C.A., and Kashyap M.L. Relationship between post-heparin plasma lipases, triglycerides and high density lipoproteins in normal subjects. Horm Metab Res 22 (1990) 289-294
19. Patsch J.R., Prasad S., Gotto Jr. A.M., and Patsch W. High density lipoprotein2. Relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase. J Clin Invest 80 (1987) 341-347
20. Uiterwaal C.S., Grobbee D.E., Witteman J.C., van Stiphout W.A., Krauss X.H., Havekes L.M., et al. Postprandial triglyceride response in young adult men and familial risk for coronary atherosclerosis. Ann Intern Med 121 (1994) 576-583
21. Tiret L., Gerdes C., Murphy M.J., Dallongeville J., Nicaud V., O'Reilly D.S., et al. Postprandial response to a fat tolerance test in young adults with a paternal history of premature coronary heart disease - the EARS II study (European Atherosclerosis Research Study). Eur J Clin Invest 30 (2000) 578-585
22. Burstein M., Scholnick H.R., and Morfin R. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res 11 (1970) 583-595
23. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
24. Olivecrona T. Determination and clinical significance of lipoprotein lipase and hepatic lipase. In: Rifai N., Warnwick G., and Dominiczak M. (Eds). Handbook of lipoprotein testing (2000), AACC Press, Washington DC 429-497
25. Nordøy A., Hansen J.B., Brox J., and Svensson B. Effects of atorvastatin and n-3 fatty acids on LDL subfractions and postprandial hyperlipemia in patients with combined hyperlipemia. Nutr Metab Cardiovasc Dis 11 (2001) 7-16
26. Slyper A.H., Zvereva S., Schectman G., Hoffmann R.G., Pleuss J., and Walker J.A. Normal postprandial lipemia and chylomicron clearance in offspring of parents with early coronary artery disease. J Clin Endocrinol Metab 83 (1998) 1106-1113
27. Cohn J.S., McNamara J.R., Cohn S.D., Ordovas J.M., and Schaefer E.J. Postprandial plasma lipoprotein changes in human subjects of different ages. J Lipid Res 29 (1988) 469-479
28. Cassader M., Gambino R., Ruiu G., Marena S., Bodoni P., and Pagano G. Postprandial triglyceride-rich lipoprotein changes in elderly and young subjects. Aging (Milano) 8 (1996) 421-428
29. Williams K.J., and Tabas I. The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol 15 (1995) 551-561
30. Cohn J.S. Postprandial lipemia: emerging evidence for atherogenicity of remnant lipoproteins. Can J Cardiol 14 Suppl. B (1998) 18B-27B
31. Proctor S.D., and Mamo J.C. Retention of fluorescent-labelled chylomicron remnants within the intima of the arterial wall-evidence that plaque cholesterol may be derived from post-prandial lipoproteins. Eur J Clin Invest 28 (1998) 497-503
32. Bradley W.A., and Gianturco S.H. Triglyceride-rich lipoproteins and atherosclerosis: pathophysiological considerations. J Intern Med Suppl 736 (1994) 33-39
33. Przybycien K., Kornacewicz-Jach Z., Torbus-Lisiecka B., and Naruszewicz M. Is abnormal postprandial lipemia a familial risk factor for coronary artery disease in individuals with normal fasting concentrations of triglycerides and cholesterol?. Coron Artery Dis 11 (2000) 377-381
34. Henderson H.E., Kastelein J.J.P., Zwinderman A.H., Gagne E., Jukema J.W., Reymer P.W.A., et al. Lipoprotein lipase activity is decreased in a large cohort of patients with coronary artery disease and is associated with changes in lipids and lipoproteins. J Lipid Res 40 (1999) 735-743
35. Miller G.J., and Miller N.E. Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease. Lancet 1 (1975) 16-19
36. Reymer P.W., Gagne E., Groenemeyer B.E., Zhang H., Forsyth I., Jansen H., et al. A lipoprotein lipase mutation (Asn291Ser) is associated with reduced HDL cholesterol levels in premature atherosclerosis. Nat Genet 10 (1995) 28-34
37. Nordestgaard B.G., Abildgaard S., Wittrup H.H., Steffensen R., Jensen G., and Tybjaerg-Hansen A. Heterozygous lipoprotein lipase deficiency: frequency in the general population, effect on plasma lipid levels, and risk of ischemic heart disease. Circulation 96 (1997) 1737-1744
38. Gagne S.E., Larson M.G., Pimstone S.N., Schaefer E.J., Kastelein J.J., Wilson P.W., et al. A common truncation variant of lipoprotein lipase (Ser447X) confers protection against coronary heart disease: the Framingham Offspring Study. Clin Genet 55 (1999) 450-454